Skip to main content

ANGIODYNAMICS INC

For the period ended Nov 30, 2024. Filed Jan 8, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Nov 30, 2024 · Filed Jan 8, 2025

ANGO$12.07-0.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Cash Flows (unaudited)

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands of dollars)

Six Months Ended
Nov 30, 2024Nov 30, 2023
Cash flows from operating activities:
Net income (loss)$(23,536)$16,836
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization13,64813,373
Non-cash lease expense993957
Stock based compensation5,7336,021
Gain on disposal of assets—(47,842)
Transaction costs for disposition—(2,427)
Change in fair value of contingent consideration23291
Deferred income taxes(588)4,951
Change in accounts receivable allowances388549
Fixed and intangible asset impairments and disposals59239
Write-off of other assets—869
Other119(138)
Changes in operating assets and liabilities:
Accounts receivable50677
Inventories(5,303)(8,844)
Prepaid expenses and other(72)(4,979)
Accounts payable, accrued and other liabilities(7,503)(966)
Net cash used in operating activities(15,780)(20,633)
Cash flows from investing activities:
Additions to property, plant and equipment(1,889)(1,345)
Additions to placement and evaluation units(2,477)(2,006)
Proceeds from sale of assets—100,000
Net cash (used in) provided by investing activities(4,366)96,649
Cash flows from financing activities:
Repayment of long-term debt—(50,000)
Payment of acquisition related contingent consideration—(10,000)
Repurchase of common stock(1,670)—
Proceeds from exercise of stock options and employee stock purchase plan3858
Net cash used in financing activities(1,632)(59,942)
Effect of exchange rate changes on cash and cash equivalents(189)202
Increase (decrease) in cash and cash equivalents(21,967)16,276
Cash and cash equivalents at beginning of period76,05644,620
Cash and cash equivalents at end of period$54,089$60,896
Supplemental disclosure of non-cash investing and financing activities:
Accrual for capital expenditures incurred during the period$411$(138)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.